Cargando…
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
Septic shock still has a high mortality rate which has not hinted at decreasing in recent years. Unfortunately, randomized trials failed mainly because the septic patient was considered as a homogeneous entity. All this creates a sort of therapeutic impotence in everyday clinical practice in treatin...
Autores principales: | Busani, Stefano, Roat, Erika, Tosi, Martina, Biagioni, Emanuela, Coloretti, Irene, Meschiari, Marianna, Gelmini, Roberta, Brugioni, Lucio, De Biasi, Sara, Girardis, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930614/ https://www.ncbi.nlm.nih.gov/pubmed/33681248 http://dx.doi.org/10.3389/fmed.2021.616511 |
Ejemplares similares
-
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
por: Coloretti, Irene, et al.
Publicado: (2021) -
The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017) -
Early use of immunoglobulin in septic shock
por: Cavazzuti, IC, et al.
Publicado: (2010) -
Difference in PaO(2)/FiO(2) between high-flow nasal cannula and Venturi mask in hypoxemic COVID-19 patients
por: Gatto, Ilenia, et al.
Publicado: (2022) -
Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
por: Serafini, G, et al.
Publicado: (2012)